The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
LIC won’t sell stake in NSE IPO OFS, betting on exchange’s long-term potential
Life Insurance Corporation of India will not sell its stake in the National Stock Exchange’s IPO. LIC holds a significant 10.7% stake in NSE. The